B lymphocyte-typing for prediction of clinical response to rituximab.
about
CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis.Immune cell profiling to guide therapeutic decisions in rheumatic diseasesA combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study.Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal?Circulating (CD3(-)CD19(+)CD20(-)IgD(-)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
P2860
B lymphocyte-typing for prediction of clinical response to rituximab.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
B lymphocyte-typing for prediction of clinical response to rituximab.
@ast
B lymphocyte-typing for prediction of clinical response to rituximab.
@en
type
label
B lymphocyte-typing for prediction of clinical response to rituximab.
@ast
B lymphocyte-typing for prediction of clinical response to rituximab.
@en
prefLabel
B lymphocyte-typing for prediction of clinical response to rituximab.
@ast
B lymphocyte-typing for prediction of clinical response to rituximab.
@en
P2093
P2860
P356
P1476
B lymphocyte-typing for prediction of clinical response to rituximab.
@en
P2093
Franz Rainer
Hans-Peter Brezinschek
Kerstin Brickmann
Winfried B Graninger
P2860
P2888
P356
10.1186/AR3901
P577
2012-07-06T00:00:00Z
P5875
P6179
1014853291